LINC02817

Across TCGA pan-cancer cohorts, LINC02817 RNA differs between tumor and matched normal tissue in 14 of 18 cancer types tested, making tumor–normal expression one of LINC02817’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where LINC02817 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02817 is over-expressed in tumor, although a few such as LUSC and LUAD show the opposite, repressed pattern.

LUSC, LUAD, and BLCA are the cancer types where LINC02817 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02817 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	Female	II,III,IV	−0.302	<.001	9	view →
LUAD	Female	III,IV	−0.283	<.001	8	view →
BLCA	All	All	−0.213	.002	7	view →
KICH	All	All	−0.059	<.001	7	view →
BRCA	All	III,IV	−0.172	<.001	6	view →
UCEC	All	All	−0.154	<.001	6	view →
KIRC	Male	All	+0.025	.003	5	view →
THCA	Female	All	−0.020	<.001	4	view →
LIHC	All	All	+0.263	.004	3	view →
ESCA	All	All	−0.051	.023	3	view →
STAD	All	All	−0.033	.007	3	view →
PRAD	All	All	−0.124	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 14 lineages.

LINC02817–LUSC

Open the LUSC breakdown →